Morgan Stanley Upgrades Merck KGaA to “Overweight” (MRK)
Merck KGaA (FRA:MRK) was upgraded by research analysts at Morgan Stanley to an “overweight” rating in a report released on Monday, AmericanBankingNews.com reports.
Separately, analysts at BMO Capital Markets upgraded shares of Merck KGaA from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, November 1st. They now have a €50.00 ($68.49) price target on the stock, up previously from €4.00 ($5.48). Five analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of €92.59 ($126.83).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.